ArticleNeurochemical research2025
ALG13 Deficiency and Epilepsy-Related Cognitive Impairment: Role of the DDIT4-Mediated PI3K/AKT/mTOR Pathway.
Article in Neurochemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Importance of apparatus scaling in novel object recognition for juvenile and adult rats.Physiology & behavior · 2026Article
- NovelHuman mutation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveThis study aimed to investigate the impact of ALG13 deficiency on cognitive function in mice.
methodsCognitive behavior in Alg13 knockout (KO) mice was assessed using the IntelliCage system (free exploration, nosepoke learning, spatial learning, and reversal learning) and the Smart 3.0 system (open-field activity, novel object recognition, and spatial object recognition). Social cognition was evaluated through three-chamber sociability, novelty preference, and social recognition memory tests. RNA sequencing and bioinformatic analyses were conducted to explore potential molecular mechanisms.
resultsWhen housed separately, Alg13 KO mice exhibited impaired free exploration, nosepoke learning, and spatial reversal learning compared to wild-type (WT) controls; however, co-housing eliminated these differences, with no significant disparities in free exploration, nosepoke learning, spatial learning, or spatial reversal learning. Notably, Alg13 KO mice had significantly lower error rates in spatial position learning and spatial position reversal learning. In behavioral analyses using Smart 3.0 tracking, Alg13 KO mice were found to exhibit diminished locomotor activity in the open-field task, impaired novel object recognition, and reduced spatial novelty exploration. In social cognition tests, both WT mice and Alg13 KO mice showed a preference for novel stimuli, but WT mice showed superior learning abilities compared to Alg13 KO mice. Furthermore, downregulation of the hub gene Ddit4 and activated PI3K/AKT/mTOR signaling pathway were identified in RNA sequencing.
conclusionALG13 deficiency results in cognitive impairment in mice, potentially mediated by dysregulation of the DDIT4-PI3K/AKT/mTOR signaling pathway.
Indexed as
Identifiers
40622409What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.